Acute stent thrombosis (AST) is associated with increased morbidity and mortality. The main
aim of this study was to evaluate the prognostic value of the systemic immune-inflammation …

The no-reflow phenomenon refers to the post-percutaneous coronary intervention condition
in which, despite re-establishing epicardial coronary vessel patency, the flow to the …

C-reactive protein (CRP) and high-sensitivity CRP (hsCRP), along with a series of
hematological indices, platelet to lymphocyte ratio (PLR), neutrophil to lymphocyte ratio …

Currently, the gold standard treatment for ST-elevation myocardial infarction (STEMI) is
primary percutaneous coronary intervention (pPCI), but even after successful pPCI, a …

After cardiac arrest, organ damage consequent to ischemia‐reperfusion has been attributed
to oxidative stress. Mild therapeutic hypothermia has been applied to reduce this damage …

Aims: Soluble suppression of tumorigenicity 2 (sST2) was validated to independently predict
prognosis for heart failure (HF) and ST-segment elevation myocardial infarction (STEMI). In …

Objective We aimed to investigate the association between platelet-leukocyte aggregates
(PLA) levels on admission and the risk of myocardial no-reflow in patients with ST elevation …

We investigated whether admission estimated glomerular filtration rate (eGFR) values are
associated with no-reflow phenomenon in patients with ST-segment elevation myocardial …

In the pathogenesis of atherosclerosis, oxidative stress plays a major role in plaque
instability, rupture, and erosion, which subsequently leads to thrombus formation and …

Introduction No-reflow phenomenon (NRP) is one of the complications that mostly occur
during percutaneous coronary intervention (PCI). In this study, we comprehensively …